Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLBB.L Regulatory News (LBB)

  • There is currently no data for LBB

Interim Results

30 Sep 2008 07:00

RNS Number : 6061E
Molectra Group Ltd
30 September 2008
 



For Immediate Release

30 September 2008

Molectra Group Limited (the "Company")

Unaudited interim results for the 6 months ended 30 June 2008

Molectra Group Limited (AIM:MOLE), (formerly the Greenhouse Fund Limited), today reports its unaudited interim results for the 6 months ended 30 June 2008. 

Highlights for the period:

Additional investment in Molectra Australia

Two re-bonded crumb rubber contracts awarded

Highlights post period end:

Acquired remaining minority interests in Molectra Australia

Change in strategy from fund to operating company

Name change to Molectra Group Limited

New board appointments

Paul Gazzard, Chief Executive Officer commented: "The year to date has seen a transformation in both Molectra's operations and the Company's structure. The award of our first two contracts for re-bonded crumb rubber mark the change in Molectra's technology from the research and development phase to a commercially viable process.

The structural changes made to Molectra have created a well funded company with a highly experienced management team and an exciting technology. With several negotiations ongoing which may lead to further contracts, we view Molectra's future with confidence."

For further information please contact:

Molectra Group Ltd

 

Paul Gazzard 

01725 510 383 

Rodger Sargent

020 7355 7660

Matrix Corporate Capital LLP

Stephen Mischler

020 3206 7203

Tim Graham

0203 206 7206

Threadneedle Communications Ltd

Graham Herring

020 7653 9850

CHAIRMAN'S STATEMENT

These unaudited interim accounts cover the six months to 30 June 2008. 

Financial performance

As at 30 June 2008, the Company had net assets of £12,833,702 (2007: £13,574,110). The loss for the period was £1,465,372 (2007: £238,052) and the period end NAV was 8.27p (2007:8.74p). The increased loss was due to significantly increased corporate activity compared to the previous period, which resulted in large due diligence, legal and accounting costs.  

Portfolio update

Molectra Australia Pty Ltd ('MA') 

Development continued at Molectra Australia throughout the period. On 10 March 2008, MA entered into its first value added product ('VAP') contract, to supply anti-cast products made from its recycled re-bonded crumb rubber to the equine market. Anti-cast products are used to create a soft and impact resistant surface on stable walls to prevent injury to horses. The contract will be supplied out of the Brisbane plant, to an individual trading as HorseFabulous Products & Equipment, for distribution across Australasia.

On 10 June 2008, a second contract, to supply rubber automotive accessory products to an Australian distributor, was won. It is very encouraging that, despite Brisbane being a pilot plant, MA is able to enter commercial agreements and this bodes well for the future, once production volumes and efficiencies are improved.  

On 15 April 2008, it was announced that the AUD$1,700,000 outstanding loan from Molectra to MA would be repaid by the issue of further shares in Molectra, taking the Company's stake in MA to 64.3 per cent. 

There were significant post period end developments that are covered below. 

Other investments 

The five Bauxsol technology sub-licences are non-core to the Company's future strategy. A strategic review to maximise shareholder value from the licenses is currently under way, the outcome of which will be announced in due course. 

Post period developments 

On 16 July 2008, it was announced that the Company had agreed, subject to the approval of shareholders at an EGM, to acquire the 35.7% of MA's share capital that it did not already own. The consideration for the acquisition would be satisfied by the issue of 32,000,000 new Molectra ordinary shares. In addition, it was announced that the Company would acquire the intellectual property which MA relies upon for its business, for a consideration of 16,000,000 new ordinary shares. 

It was also proposed that Paul Gazzard and Rodger Sargent, directors of the Greenhouse Strategic Adviser, join the Board of the Company, along with John Dobozy, the inventor of the Molectra technology, and David Hassum 

Given that the nature of the Company's business would be transformed by these proposals, it was also proposed that the Company's name be changed to Molectra Group Limited. It was further proposed that the Company would cease being an externally managed investment company and would become an internally managed company whose principal business would be conducted through its wholly owned subsidiary, MA

These proposals represented a fundamental change in the business, board and voting control of the Company, and constituted a reverse takeover under the AIM Rules, requiring the approval of shareholders at an EGM. All resolutions were passed by shareholders at the EGM, held on 12 August 2008.

The acquisition and change in strategy allows the Company to concentrate principally on the continued commercialisation of the MA tyre recycling process. Short term prospects involve securing additional contracts for the production and supply of the higher margin re-bonded crumb rubber products and, to date, two such contracts have been awarded, whilst discussions are continuing with a number of parties both in Australia and overseas which may lead to additional contracts being secured

Further investment will be made to enhance the production facility and increase capacity to accommodate the increasing production demand for VAP's. However, a key strategy for growth is the opportunity to establish tyre recycling plants for third parties, which is a potentially significant area of expansion. Target industries for such plants include the mining and waste management industries, where there are restrictions and regulations on the disposal of waste tyres. Over the medium to long term the Company will also continue to improve the MolectraVac microwave technology and seek to produce a carbon based product stream that is commercially viable.

The change of strategy from the portfolio approach of The Greenhouse Fund Limited to sole development of Molectra presents an exciting opportunity which I hope will allow to us to fully commercialise and enjoy the tremendous potential of Molectra's product range. I look forward to the future with great optimism.

Roger Maddock

Non-executive Director

Molectra Group Limited

30 September 2008

  

MOLECTRA GROUP LIMITED

Consolidated Condensed Interim Income Statement (Unaudited) 

For the six months ended 30 June 2008

(unaudited)

(unaudited)

01 January 2008

01 January 2007

to 30 June 2008

to 30 June 2007

£

Revenue

Bank interest

20,010 

6,088 

Deposit interest

122,193

184,477 

Other income

15,102

-

Total Income

157,305

190,565 

Operating expenses

Management fees

 

(97,732)

(97,195)

Other operating expenses

(1,212,478)

(198,246)

Amortisation of intangible asset

(231,438)

(133,176)

Depreciation of plant, property, and equipment

(35,247)

-

Total operating expenses

(1,576,896)

(428,617)

Taxation

(45,782)

-

Net loss for the period

(1,465,372)

(238,052)

Attributable to:

Equity holders of the company

(1,364,397)

(238,052)

Minority interest

(100,975)

-

Net loss for the period

(1,465,372)

(238,052)

Basic and diluted loss per share (pence)

(0.88)

(0.15)

All transactions arise from continuing operations.

  

MOLECTRA GROUP LIMITED

Consolidated Condensed Interim Balance Sheet (Unaudited)

As at 30 June 2008

(unaudited)

(unaudited)

30 June 2008

30 June 2007

£

£

Non-Current Assets

Intangible assets

8,959,928

4,938,365 

Investments held at fair value

-

1,988,847 

Property, plant and equipment

723,664

-

9,683,592

6,927,212 

Current assets

Other receivables

57,636

24,204 

Cash and cash equivalents

 

4,505,523

6,672,737 

4,563,159

6,696,941 

 

Total assets

14,246,751

13,624,153 

Current liabilities

Other payables

(198,288)

(50,043)

Non-current liabilities

Deferred income tax liabilities

(1,214,761)

-

Net assets

12,833,702

13,574,110 

Equity

Share capital

14,116,977

14,116,977 

Other reserve

1,509

-

Retained earnings

(2,144,052)

(542,867)

11,974,434

13,574,110

Minority interest

859,268

-

Total Equity

12,833,702

13,574,110 

NAV per Ordinary share (pence)

8.27

8.74

 

These financial statements were approved by the Board of Directors and signed on 30th September 2008.

  

MOLECTRA GROUP LIMITED

Condensed Interim Statement of Cash Flows (Unaudited)

For the six months ended 30 June 2008

(unaudited)

(unaudited)

01 January 2008

01 January 2007

to 30 June 2008

to 30 June 2007

£

£

Cash flow from operating activities

Net loss for period

(1,465,372)

(238,052)

Amortisation

266,685

133,176 

Increase in deferred tax liability

45,782

Decrease in other receivables

149,299

13,977 

Decrease in other payables

(352,328)

(6,752)

Net cash outflow from operating activities 

(1,355,934)

(97,651)

Cash flow from investing activities

Purchase of property, plant, and equipment

(170,513)

-

Purchase of unlisted investments

-

(1,269,973)

Purchase of intangible investments

-

 

(128,740)

Net cash outflow from investing activities

(170,513)

(1,398,713)

Cash flow from financing activities

Issue of Ordinary shares 

-

 

Sales commission and formation costs paid

-

-

Net cash inflow from financing activities

-

- 

 

Net decrease in cash and cash equivalents

(1,526,447)

(1,496,364) 

Cash and cash equivalents at start of the period

6,031,970

8,169,101

Cash and cash equivalents at 30 June

4,505,523

6,672,737 

MOLECTRA GROUP LIMITED

Notes to the Condensed Interim Financial Statements (Unaudited)

1 Basis of accounting

The Group financial statements are prepared under International Financial Reporting Standards (IFRS) as adopted by the EU. This statement has been prepared using accounting policies & presentation consistent with those applied in the preparation of the accounts for the Group for the year ended 31st December 2007 and are not the company's statutory accounts for the purposes of section 240 of the Companies Act 1985.

2

 Earnings per share

The earnings per Ordinary share is based on the net loss for the period of £1,465,372 (30 June 2007:£238,052);

and on 155,225,000 (30 June 2007:155,225,000) weighted average Ordinary shares.

The diluted return per Ordinary share is based on the net loss for the period and 155,225,000 shares. There are no potentially 

dilutive Ordinary shares.

3

 Management fee

01 January 2008

01 January 2007

 

to 30 June 2008

to 30 June 2007

£

£

Management fee

97,732

97,195

The management fee paid to Development Capital Management (Jersey) Limited is 2% per annum of the amount 

subscribed plus any gains retained by the Fund for reinvestment.

The management agreement between the Fund and the Manager is terminable by either party on twelve month's

notice, subject to an initial term of 36 months from admission.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR SEIFIUSASELU
Date   Source Headline
8th Aug 20117:00 amRNSTrading update and successful fundraising
6th Jul 20117:00 amRNSTrading Statement
1st Jul 20117:00 amRNSFirst Order From Germany and Austria
20th Jun 20117:00 amRNSLeading Norwegian retailer places $195k re-order
16th Jun 20117:00 amRNSDirector Dealing
19th Apr 20115:40 pmRNSDirector/PDMR Shareholding
13th Apr 20112:43 pmRNSIssue of Equity and Director Shareholding
5th Apr 20119:53 amRNSDirector/PDMR Shareholding
30th Mar 20117:00 amRNSInterim Results
16th Mar 20117:00 amRNSAcquisition
17th Jan 20117:00 amRNSScandanavian Order
6th Jan 20118:25 amRNSHolding(s) in Company
29th Dec 20102:28 pmRNSHolding(s) in Company
20th Dec 20104:19 pmRNSResult of AGM
20th Dec 20107:00 amRNSNew North America Agents
6th Dec 20107:01 amRNSIssue of Equity
6th Dec 20107:00 amRNSFinal Results
7th Oct 20107:00 amRNSMarks & Spencer re-order
29th Sep 20107:00 amRNSHolding(s) in Company
17th Sep 201010:24 amRNSHolding(s) in Company
15th Sep 20107:10 amRNSCanadian Order
15th Sep 20107:05 amRNSHouse of Fraser
15th Sep 20107:00 amRNSChange of Adviser
13th Sep 20104:50 pmRNSHolding(s) in Company
3rd Aug 20108:56 amRNSPlacing and New Contract - Replacement
3rd Aug 20107:00 amRNSPlacing and New Contract
28th Jul 20107:00 amRNSAPI Australia order
25th Jun 20107:01 amRNSResults Announcement
25th Jun 20107:00 amRNSOrder Announcement
14th Jun 20107:00 amRNSOrder in South Africa and Director Appointment
9th Jun 20107:00 amRNSOrder Announcement
17th May 20107:00 amRNSSecond Canadian Retailer
21st Apr 20107:00 amRNSNew Finland Retailer
13th Apr 20102:49 pmRNSSubsidiary Accounts filed at Companies House
24th Mar 20107:00 amRNSDirectorate Change
10th Mar 20107:00 amRNSChange of Name
8th Mar 20109:33 amRNSHolding(s) in Company
5th Mar 20109:35 amRNSCompletion of Acquisition
4th Mar 20104:16 pmRNSStatement re Issue of Equity
4th Mar 201011:36 amRNSResult of EGM
24th Feb 20103:52 pmRNSHolding(s) in Company
22nd Feb 201012:06 pmRNSHolding(s) in Company
16th Feb 20105:04 pmRNSHolding(s) in Company
15th Feb 20107:30 amRNSRestoration - Baylon Holdings Limited
15th Feb 20107:30 amRNSAcquisition
28th Jan 201012:54 pmRNSHolding(s) in Company
26th Jan 201010:27 amRNSHolding(s) in Company
22nd Jan 201012:03 pmRNSDisposal
13th Jan 20106:30 pmRNSResult of EGM
6th Jan 20103:22 pmRNSResignation of non-executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.